156 related articles for article (PubMed ID: 26848098)
1. Real-time RT-PCR systems for CTC detection from blood samples of breast cancer and gynaecological tumour patients (Review).
Andergassen U; Kölbl AC; Mahner S; Jeschke U
Oncol Rep; 2016 Apr; 35(4):1905-15. PubMed ID: 26848098
[TBL] [Abstract][Full Text] [Related]
2. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
Obermayr E; Sanchez-Cabo F; Tea MK; Singer CF; Krainer M; Fischer MB; Sehouli J; Reinthaller A; Horvat R; Heinze G; Tong D; Zeillinger R
BMC Cancer; 2010 Dec; 10():666. PubMed ID: 21129172
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment.
Bredemeier M; Edimiris P; Tewes M; Mach P; Aktas B; Schellbach D; Wagner J; Kimmig R; Kasimir-Bauer S
Oncotarget; 2016 Jul; 7(27):41677-41690. PubMed ID: 27223437
[TBL] [Abstract][Full Text] [Related]
4. Epithelial‑mesenchymal transition was identified as a potential marker for breast cancer aggressiveness using reverse transcription‑quantitative polymerase chain reaction.
Andergassen U; Schlenk K; Jeschke U; Sommer H; Kölbl A
Mol Med Rep; 2018 Aug; 18(2):1733-1739. PubMed ID: 29845200
[TBL] [Abstract][Full Text] [Related]
5. New Marker Genes for Real-Time PCR-based Detection of Circulating Tumour Cells from Blood of Breast Cancer Patients.
Kölbl AC; Bräuer D; Hutter S; Rack B; Friese K; Jeschke U; Andergassen U
Anticancer Res; 2016 Jun; 36(6):3211-6. PubMed ID: 27272851
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer.
Ueo H; Sugimachi K; Gorges TM; Bartkowiak K; Yokobori T; Müller V; Shinden Y; Ueda M; Ueo H; Mori M; Kuwano H; Maehara Y; Ohno S; Pantel K; Mimori K
Br J Cancer; 2015 Apr; 112(9):1519-26. PubMed ID: 25880010
[TBL] [Abstract][Full Text] [Related]
7. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
[TBL] [Abstract][Full Text] [Related]
8. Identification of circulating tumour cells in early stage breast cancer patients using multi marker immunobead RT-PCR.
Raynor MP; Stephenson SA; Pittman KB; Walsh DC; Henderson MA; Dobrovic A
J Hematol Oncol; 2009 Jun; 2():24. PubMed ID: 19500345
[TBL] [Abstract][Full Text] [Related]
9. Detection of circulating breast tumor cells by differential expression of marker genes.
Bosma AJ; Weigelt B; Lambrechts AC; Verhagen OJ; Pruntel R; Hart AA; Rodenhuis S; van 't Veer LJ
Clin Cancer Res; 2002 Jun; 8(6):1871-7. PubMed ID: 12060630
[TBL] [Abstract][Full Text] [Related]
10. Detection of circulating tumour cells in blood by quantitative real-time RT-PCR: effect of pre-analytical time.
Benoy IH; Elst H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
Clin Chem Lab Med; 2006; 44(9):1082-7. PubMed ID: 16958599
[TBL] [Abstract][Full Text] [Related]
11. Real-time quantitative RT-PCR detection of circulating tumor cells from breast cancer patients.
Guo M; Li X; Zhang S; Song H; Zhang W; Shang X; Zheng Y; Jiang H; Lv Q; Jiang Y; Hao H
Int J Oncol; 2015 Jan; 46(1):281-9. PubMed ID: 25353649
[TBL] [Abstract][Full Text] [Related]
12. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
[TBL] [Abstract][Full Text] [Related]
13. Detection of tumor cell-specific mRNA in the peripheral blood of patients with breast cancer—evaluation of several markers with real-time reverse transcription-PCR.
Andergassen U; Hofmann S; Kölbl AC; Schindlbeck C; Neugebauer J; Hutter S; Engelstädter V; Ilmer M; Friese K; Jeschke U
Int J Mol Sci; 2013 Jan; 14(1):1093-104. PubMed ID: 23299436
[TBL] [Abstract][Full Text] [Related]
14. Molecular detection of peripheral blood breast cancer mRNA transcripts as a surrogate biomarker for circulating tumor cells.
Lasa A; Garcia A; Alonso C; Millet P; Cornet M; Ramón y Cajal T; Baiget M; Barnadas A
PLoS One; 2013; 8(9):e74079. PubMed ID: 24058517
[TBL] [Abstract][Full Text] [Related]
15. Detection of circulating tumor cells in patients with breast cancer using the quantitative RT-PCR assay for monitoring of therapy efficacy.
Wang HY; Ahn S; Kim S; Park S; Park S; Han H; Sohn JH; Kim S; Lee H
Exp Mol Pathol; 2014 Dec; 97(3):445-52. PubMed ID: 25217799
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
[TBL] [Abstract][Full Text] [Related]
17. Quantification of breast cancer cells in peripheral blood samples by real-time rt-PCR.
Zebisch M; Kölbl AC; Schindlbeck C; Neugebauer J; Heublein S; Ilmer M; Rack B; Friese K; Jeschke U; Andergassen U
Anticancer Res; 2012 Dec; 32(12):5387-91. PubMed ID: 23225441
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR.
Sieuwerts AM; Kraan J; Bolt-de Vries J; van der Spoel P; Mostert B; Martens JW; Gratama JW; Sleijfer S; Foekens JA
Breast Cancer Res Treat; 2009 Dec; 118(3):455-68. PubMed ID: 19115104
[TBL] [Abstract][Full Text] [Related]
19. Blood presence of circulating oncofetal fibronectin mRNA, by RT-PCR, does not represent a useful specific marker for the management and follow-up of thyroid cancer patients.
Vendittelli F; Raffaelli M; Fadda G; Carelli-Alinovi C; Paolillo C; Bellantone R; Zuppi C; Capoluongo E
Clin Chem Lab Med; 2012 Jan; 50(4):715-20. PubMed ID: 22505562
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor as a novel marker for detection of circulating cancer cells.
Otero LL; Alonso DF; Castro M; Cinat G; Gabri MR; Gomez DE
Biomarkers; 2011 Feb; 16(1):58-64. PubMed ID: 21128872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
